Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,412 | 1,340 | 1,664 | 2,761 | 2,544 |
| Operating Income | -2,412 | -1,340 | -1,664 | -2,761 | -2,544 |
| Interest Expense | 60 | 60 | 60 | 32 | 0 |
| Other Income | 271 | 50 | 71 | 75 | 63 |
| Pre-tax Income | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 |
| Net Income Continuous | -2,201 | -1,350 | -1,654 | -2,717 | -2,481 |
| Net Income | $-2,201 | $-1,350 | $-1,654 | $-2,717 | $-2,481 |
| EPS Basic Total Ops | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | -0.06 | -0.11 | -0.10 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.05 | -0.06 | -0.11 | -0.10 |
| EBITDA(a) | $-2,352 | $-1,281 | $-1,605 | $-2,761 | $-2,544 |